Transplanting cells into livers has the potential to completely regenerate them, say scientists.The Medical Research Council team showed severely damaged organs in mice could be restored to near-normal function. They say the findings, published in Nature Cell Biology, could eventually help people stuck on a…
Author: Dave Hollis
HIV: UN Meets Goal To Treat 15 Million
The goal to get HIV treatment to 15 million people by the end of 2015 has already been met, says the United Nations Aids agency.The landmark figure was reached in March – nine months ahead of schedule. It follows decades of global efforts and investment…
Smoking ‘May Play Schizophrenia Role’
Smoking could play a direct role in the development of schizophrenia and needs to be investigated, researchers say.The team at King’s College London say smokers are more likely to develop the disorder and at a younger age. Published in the Lancet Psychiatry, their analysis of…
Deafness Could Be Treated By Virus, Say Scientists
Scientists say they have taken a significant step towards treating some forms of deafness after restoring hearing in animals.Defects in a baby’s DNA are behind roughly half of cases of hearing loss in early life. The mouse study, published in Science Translational Medicine, showed a…
A Better Genetic Inheritance: How Couples Are Breeding Disease Out Of Their Families
There are new methods — some scientifically advanced, others old fashioned, but all controversial — that couples are using to helt the spread of dangerous genes that have stricken families for generations. Love at first sight? Easy enough. But what about couples who fall in…
Industry ‘Must Do More’ To Improve Urinary Catheters
A leading researcher says industry must “wake up and invest more” in urinary cathetersMandy Fader, professor of continence technology at the University of Southampton, says their design has changed “very little” in 80 years. In the Surgical Blog Scrubbing Up column, she criticises low investment…
Strategies in The Global Hemostasis Diagnostic Testing Market 2015-2020
This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years. The report explores business and technological trends in…
Salix Announces FDA Approval Of Xifaxan® 550 mg For The Treatment Of IBS-D (Irritable Bowel Syndrome With Diarrhea)
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that its wholly owned subsidiary, Salix Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for Xifaxan® 550 mg for the treatment of IBS-D in adults. The FDA approval of Xifaxan 550…